Page last updated: 2024-09-05

organophosphonates and Hormone-Dependent Neoplasms

organophosphonates has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakuma, J; Asano, T; Hayakawa, M; Nanus, DM; Sumitomo, M1
Ahmann, F; Blumenstein, B; Craig, JB; Crawford, ED; Eisenberger, M; Marshall, ME; Thompson, IM1

Trials

1 trial(s) available for organophosphonates and Hormone-Dependent Neoplasms

ArticleYear
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
    American journal of clinical oncology, 1994, Volume: 17, Issue:6

    Topics: Adenine; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasms, Hormone-Dependent; Organophosphonates; Prostatic Neoplasms; Remission Induction

1994

Other Studies

1 other study(ies) available for organophosphonates and Hormone-Dependent Neoplasms

ArticleYear
Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-01, Volume: 10, Issue:1 Pt 1

    Topics: Androgens; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Drug Resistance, Neoplasm; Epithelial Cells; Etoposide; Humans; Male; Mitochondria; Neoplasms, Hormone-Dependent; Neprilysin; Organophosphonates; Phenylalanine; Prostate; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-delta; Recombinant Proteins

2004